Publicaciones en las que colabora con José Luis Fernández Luna (10)

2016

  1. Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

    Nature Communications, Vol. 7

2006

  1. Identification of c-Kit gene mutations in patients with polycythemia vera

    Leukemia Research

2004

  1. Imatinib Inhibits Proliferation of Ewing Tumor Cells Mediated by the Stem Cell Factor/KIT Receptor Pathway, and Sensitizes Cells to Vincristine and Doxorubicin-Induced Apoptosis

    Clinical Cancer Research, Vol. 10, Núm. 2, pp. 751-761

  2. NALP1 is a transcriptional target for cAMP-response-element-binding protein (CREB) in myeloid leukaemia cells

    Biochemical Journal, Vol. 384, Núm. 2, pp. 281-286

2003

  1. Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response

    Haematologica, Vol. 88, Núm. 12, pp. 1425-1426

2002

  1. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κB activation

    Journal of Biological Chemistry, Vol. 277, Núm. 44, pp. 41701-41705

  2. Nuclear factor κ B is activated in myelodysplastic bone marrow cells

    Haematologica, Vol. 87, Núm. 9, pp. 1005-1006

2001

  1. Antiapoptotic protein Bcl-xL is up-regulated during megakaryocytic differentiation of CD34+ progenitors but is absent from senescent megakaryocytes

    Experimental Hematology, Vol. 29, Núm. 6, pp. 728-735

2000

  1. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-x(L)

    Journal of Experimental Medicine, Vol. 191, Núm. 6, pp. 977-984

1999

  1. Erythropoietin can induce the expression of Bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines

    Journal of Biological Chemistry, Vol. 274, Núm. 32, pp. 22165-22169